The Approval Overview and Clinical Trial Requirements of Respiratory Multiple Pathogen Nucleic Acid Detection Kits

Xu Chao, Li Wenxia, Zheng Shengwei, He Jingyun

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (4) : 399-406.

PDF(1063 KB)
PDF(1063 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (4) : 399-406. DOI: 10.16153/j.1002-7777.2024-11-0025
Quality Management：Special Column on Quality Control Research of in vitro Diagnostic Reagents for Infectious Diseases

The Approval Overview and Clinical Trial Requirements of Respiratory Multiple Pathogen Nucleic Acid Detection Kits

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(4): 399-406 https://doi.org/10.16153/j.1002-7777.2024-11-0025

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1063 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉